BRIGHTMEDS GLP-1: A DEEP INVESTIGATION INTO THIS INNOVATIVE THERAPY

GLP-1 receptor agonists , particularly those like BrightMeds, are quickly prominence in the management of type 2 diabetes and are also explored for obesity . These novel drugs work by mimicking the body's natural incretin hormone , stimulating insulin release and reducing glucagon production . Br